These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12075941)

  • 1. Review of evidence for a connection between Chlamydia pneumoniae and atherosclerotic disease.
    Dugan JP; Feuge RR; Burgess DS
    Clin Ther; 2002 May; 24(5):719-35. PubMed ID: 12075941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlamydia pneumoniae and coronary artery disease: the antibiotic trials.
    Higgins JP
    Mayo Clin Proc; 2003 Mar; 78(3):321-32. PubMed ID: 12630585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chlamydia pneumoniae, atherosclerosis, and coronary disease].
    Monno R; Di Biase M; Costi A; de Nicolò T; Correale M; Bolognese P; Losacco G
    Ital Heart J Suppl; 2003 May; 4(5):383-97. PubMed ID: 12848076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced progression of early carotid atherosclerosis after antibiotic treatment and Chlamydia pneumoniae seropositivity.
    Sander D; Winbeck K; Klingelhöfer J; Etgen T; Conrad B
    Circulation; 2002 Nov; 106(19):2428-33. PubMed ID: 12417538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Chlamydia pneumoniae in atherosclerosis.
    Watson C; Alp NJ
    Clin Sci (Lond); 2008 Apr; 114(8):509-31. PubMed ID: 18336368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic therapy for coronary heart disease: the myth and the reality.
    Kuppuswamy VC; Gupta S
    Timely Top Med Cardiovasc Dis; 2006 Jan; 10():E2. PubMed ID: 16404482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic treatment of atherosclerosis.
    Muhlestein JB
    Curr Opin Lipidol; 2003 Dec; 14(6):605-14. PubMed ID: 14624138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease.
    Kalayoglu MV; Libby P; Byrne GI
    JAMA; 2002 Dec; 288(21):2724-31. PubMed ID: 12460096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlamydia pneumoniae-atherosclerosis link: a sound concept in search for clinical relevance.
    Neumann FJ
    Circulation; 2002 Nov; 106(19):2414-6. PubMed ID: 12417534
    [No Abstract]   [Full Text] [Related]  

  • 10. Chlamydia pneumoniae, antibiotic treatment, and early atherosclerosis.
    Liuba P; Pesonen E; Paakkari I
    Circulation; 2003 Jun; 107(22):e205; author reply e205. PubMed ID: 12796417
    [No Abstract]   [Full Text] [Related]  

  • 11. Chlamydia pneumoniae and atherosclerosis: current state and future prospectives.
    Sessa R; Nicoletti M; Di Pietro M; Schiavoni G; Santino I; Zagaglia C; Del Piano M; Cipriani P
    Int J Immunopathol Pharmacol; 2009; 22(1):9-14. PubMed ID: 19309547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlamydia pneumoniae eradication from carotid plaques. Results of an open, randomised treatment study.
    Melissano G; Blasi F; Esposito G; Tarsia P; Dordoni L; Arosio C; Tshomba Y; Fagetti L; Allegra L; Chiesa R
    Eur J Vasc Endovasc Surg; 1999 Oct; 18(4):355-9. PubMed ID: 10550273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of IgG-seropositivity to Chlamydia pneumoniae in early thrombotic events after coronary stent placement.
    da Costa CP; Neumann FJ; Kastrati A; Stallforth I; Schmid M; Joghetai N; Prebeck S; Wagner H; Miethke T
    Atherosclerosis; 2003 Jan; 166(1):171-6. PubMed ID: 12482564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia pneumoniae and atherosclerosis -- what we know and what we don't.
    Ngeh J; Anand V; Gupta S
    Clin Microbiol Infect; 2002 Jan; 8(1):2-13. PubMed ID: 11906495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody levels against Chlamydia pneumoniae and outcome of roxithromycin therapy in patients with acute myocardial infarction. Results from a sub-study of the randomised Antibiotic Therapy in Acute Myocardial Infarction (ANTIBIO) trial.
    Burkhardt U; Zahn R; Höffler U; Siegler KE; Frilling B; Weber M; Gottwik M; Wehr M; Seidel F; Rosocha S; Tebbe U; Senges J
    Z Kardiol; 2004 Sep; 93(9):671-8. PubMed ID: 15365734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial.
    Neumann F; Kastrati A; Miethke T; Pogatsa-Murray G; Mehilli J; Valina C; Jogethaei N; da Costa CP; Wagner H; Schömig A
    Lancet; 2001 Jun; 357(9274):2085-9. PubMed ID: 11445102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials.
    Andraws R; Berger JS; Brown DL
    JAMA; 2005 Jun; 293(21):2641-7. PubMed ID: 15928286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Chlamydia pneumoniae a risk factor for peripheral atherosclerosis?
    Ustünsoy H; Sivrikoz C; Sirmatel F; Bakir K; Burma O; Kazaz H
    Asian Cardiovasc Thorac Ann; 2007 Jan; 15(1):9-13. PubMed ID: 17244915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlamydia pneumoniae--an infectious risk factor for atherosclerosis?
    Campbell LA; Kuo CC
    Nat Rev Microbiol; 2004 Jan; 2(1):23-32. PubMed ID: 15035006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the role of Chlamydia pneumoniae in cardiovascular disease: a narrative review.
    Vainas T; Sayed S; Bruggeman CA; Stassen FR
    Drugs Today (Barc); 2009 Nov; 45 Suppl B():165-72. PubMed ID: 20011710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.